The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Open accessAbstract
This review provides insights on the impact of glycosylation in cancer biology and its influence in the current approaches of targeted cancer therapies in the clinical setting. The roles of glycosylation in cancer signaling, tumor progression, and metastasis are reviewed as well as glycans and glycan-binding proteins in tumor immunomodulation. Moreover, the latest reports on glycans influencing targeted therapeutic approaches in cancer are summarized. Finally, we discuss the future challenges of the field, outlining potential applications of glycan-based biomarkers for patient stratification and strategies for improving personalized cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Self-citationSiglecs and their roles in the immune system
Crocker, P. R., Paulson, J. C., & Varki, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2056 · Cited by 2,031
Precision Medicine — Personalized, Problematic, and Promising
Jameson, J. L., & Longo, D. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsb1503104 · Cited by 1,106
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Li, C.-W., Lim, S.-O., Xia, W., Lee, H.-H., Chan, L.-C., Kuo, C.-W., Khoo, K.-H., Chang, S.-S., Cha, J.-H., Kim, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms12632 · Cited by 1,091
Lau, K. S., Partridge, E. A., Grigorian, A., Silvescu, C. I., Reinhold, V. N., Demetriou, M., & Dennis, J. W. (2007) · Cell · doi:10.1016/j.cell.2007.01.049 · Cited by 914
Bennett, E. P., Mandel, U., Clausen, H., Gerken, T. A., Fritz, T. A., & Tabak, L. A. (2012) · Glycobiology · doi:10.1093/glycob/cwr182 · Cited by 876
Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis
Partridge, E. A., Le Roy, C., Di Guglielmo, G. M., Pawling, J., Cheung, P., Granovsky, M., Nabi, I. R., Wrana, J. L., & Dennis, J. W. (2004) · Science · doi:10.1126/science.1102109 · Cited by 735
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
Paszek, M. J., DuFort, C. C., Rossier, O., Bainer, R., Mouw, J. K., Godula, K., Hudak, J. E., Lakins, J. N., Wijekoon, A. C., Cassereau, L., et al. (2014) · Nature · doi:10.1038/nature13535 · Cited by 699
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
Li, C.-W., Lim, S.-O., Chung, E. M., Kim, Y.-S., Park, A. H., Yao, J., Cha, J.-H., Xia, W., Chan, L.-C., Kim, T., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.009 · Cited by 602
Posey, A. D., Schwab, R. D., Boesteanu, A. C., Steentoft, C., Mandel, U., Engels, B., Stone, J. D., Madsen, T. D., Schreiber, K., Haines, K. M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.014 · Cited by 594
Selectins: initiators of leucocyte adhesion and signalling at the vascular wall
McEver, R. P. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv154 · Cited by 575
Suppression of tumor growth and metastasis in Mgat5-deficient mice
Granovsky, M., Fata, J., Pawling, J., Muller, W. J., Khokha, R., & Dennis, J. W. (2000) · Nature Medicine · doi:10.1038/73163 · Cited by 569
Rubinstein, N., Alvarez, M., Zwirner, N. W., Toscano, M. A., Ilarregui, J. M., Bravo, A., Mordoh, J., Fainboim, L., Podhajcer, O. L., & Rabinovich, G. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00024-8 · Cited by 531
Croci, D. O., Cerliani, J. P., Dalotto-Moreno, T., Méndez-Huergo, S. P., Mascanfroni, I. D., Dergan-Dylon, S., Toscano, M. A., Caramelo, J. J., García-Vallejo, J. J., Ouyang, J., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.043 · Cited by 505
Adamczyk, B., Tharmalingam, T., & Rudd, P. M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.12.001 · Cited by 478
The tumour glyco-code as a novel immune checkpoint for immunotherapy
RodrÍguez, E., Schetters, S. T. T., & van Kooyk, Y. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2018.3 · Cited by 473
Precision glycocalyx editing as a strategy for cancer immunotherapy
Xiao, H., Woods, E. C., Vukojicic, P., & Bertozzi, C. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608069113 · Cited by 440
Jandus, C., Boligan, K. F., Chijioke, O., Liu, H., Dahlhaus, M., Démoulins, T., Schneider, C., Wehrli, M., Hunger, R. E., Baerlocher, G. M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci65899 · Cited by 439
Liu, Y.-C., Yen, H.-Y., Chen, C.-Y., Chen, C.-H., Cheng, P.-F., Juan, Y.-H., Chen, C.-H., Khoo, K.-H., Yu, C.-J., Yang, P.-C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107385108 · Cited by 424
Ladenstein, R., Pötschger, U., Valteau-Couanet, D., Luksch, R., Castel, V., Yaniv, I., Laureys, G., Brock, P., Michon, J. M., Owens, C., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30578-3 · Cited by 418
A red meat-derived glycan promotes inflammation and cancer progression
Samraj, A. N., Pearce, O. M. T., Läubli, H., Crittenden, A. N., Bergfeld, A. K., Banda, K., Gregg, C. J., Bingman, A. E., Secrest, P., Diaz, S. L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417508112 · Cited by 407
Beatson, R., Tajadura-Ortega, V., Achkova, D., Picco, G., Tsourouktsoglou, T.-D., Klausing, S., Hillier, M., Maher, J., Noll, T., Crocker, P. R., et al. (2016) · Nature Immunology · doi:10.1038/ni.3552 · Cited by 378
Gleason, M. K., Lenvik, T. R., McCullar, V., Felices, M., O'Brien, M. S., Cooley, S. A., Verneris, M. R., Cichocki, F., Holman, C. J., Panoskaltsis-Mortari, A., et al. (2012) · Blood · doi:10.1182/blood-2011-06-360321 · Cited by 373
Nutrient regulation of signaling and transcription
Hart, G. W. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.aw119.003226 · Cited by 345
Seales, E. C., Jurado, G. A., Brunson, B. A., Wakefield, J. K., Frost, A. R., & Bellis, S. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3117 · Cited by 317
A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis
Agrawal, P., Fontanals-Cirera, B., Sokolova, E., Jacob, S., Vaiana, C. A., Argibay, D., Davalos, V., McDermott, M., Nayak, S., Darvishian, F., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.007 · Cited by 303
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
Stanczak, M. A., Siddiqui, S. S., Trefny, M. P., Thommen, D. S., Boligan, K. F., von Gunten, S., Tzankov, A., Tietze, L., Lardinois, D., Heinzelmann-Schwarz, V., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120612 · Cited by 296
Itkonen, H. M., Minner, S., Guldvik, I. J., Sandmann, M. J., Tsourlakis, M. C., Berge, V., Svindland, A., Schlomm, T., & Mills, I. G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0549 · Cited by 292
Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy
Hsu, J.-M., Li, C.-W., Lai, Y.-J., & Hung, M.-C. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1892 · Cited by 286
(2002) · PubMed · Cited by 279
Sørensen, A. L., Reis, C. A., Tarp, M. A., Mandel, U., Ramachandran, K., Sankaranarayanan, V., Schwientek, T., Graham, R., Taylor-Papadimitriou, J., Hollingsworth, M. A., et al. (2006) · Glycobiology · doi:10.1093/glycob/cwj044 · Cited by 277
Self-citationSialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell–Mediated Tumor Immunity
Büll, C., Boltje, T. J., Balneger, N., Weischer, S. M., Wassink, M., van Gemst, J. J., Bloemendal, V. R., Boon, L., van der Vlag, J., Heise, T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3376 · Cited by 268
Marcos, N. T., Pinho, S., Grandela, C., Cruz, A., Samyn-Petit, B., Harduin-Lepers, A., Almeida, R., Silva, F., Morais, V., Costa, J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1921 · Cited by 258
Self-citationEsposito, M., Mondal, N., Greco, T. M., Wei, Y., Spadazzi, C., Lin, S.-C., Zheng, H., Cheung, C., Magnani, J. L., Lin, S.-H., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0309-2 · Cited by 250
Cancer-associated mucins: role in immune modulation and metastasis
Bhatia, R., Gautam, S. K., Cannon, A., Thompson, C., Hall, B. R., Aithal, A., Banerjee, K., Jain, M., Solheim, J. C., Kumar, S., et al. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-09775-0 · Cited by 232
van Vliet, S. J., Gringhuis, S. I., Geijtenbeek, T. B. H., & van Kooyk, Y. (2006) · Nature Immunology · doi:10.1038/ni1390 · Cited by 216
Cosmc is an essential chaperone for correct protein O-glycosylation
Wang, Y., Ju, T., Ding, X., Xia, B., Wang, W., Xia, L., He, M., & Cummings, R. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914004107 · Cited by 212
Telen, M. J., Wun, T., McCavit, T. L., De Castro, L. M., Krishnamurti, L., Lanzkron, S., Hsu, L. L., Smith, W. R., Rhee, S., Magnani, J. L., et al. (2015) · Blood · doi:10.1182/blood-2014-06-583351 · Cited by 211
In vivo targeting of B-cell lymphoma with glycan ligands of CD22
Chen, W. C., Completo, G. C., Sigal, D. S., Crocker, P. R., Saven, A., & Paulson, J. C. (2010) · Blood · doi:10.1182/blood-2009-12-257386 · Cited by 203
Snail1 is stabilized by O‐GlcNAc modification in hyperglycaemic condition
Park, S. Y., Kim, H. S., Kim, N. H., Ji, S., Cha, S. Y., Kang, J. G., Ota, I., Shimada, K., Konishi, N., Nam, H. W., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.254 · Cited by 202
Inhibition of N-Linked Glycosylation Disrupts Receptor Tyrosine Kinase Signaling in Tumor Cells
Contessa, J. N., Bhojani, M. S., Freeze, H. H., Rehemtulla, A., & Lawrence, T. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6389 · Cited by 201
van Gisbergen, K. P. J. M., Aarnoudse, C. A., Meijer, G. A., Geijtenbeek, T. B. H., & van Kooyk, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4140 · Cited by 192
Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation
Sundblad, V., Morosi, L. G., Geffner, J. R., & Rabinovich, G. A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701172 · Cited by 184
Ihara, S., Miyoshi, E., Ko, J. H., Murata, K., Nakahara, S., Honke, K., Dickson, R. B., Lin, C.-Y., & Taniguchi, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200673200 · Cited by 175
N -Glycosylation as determinant of epidermal growth factor receptor conformation in membranes
Kaszuba, K., Grzybek, M., Orłowski, A., Danne, R., Róg, T., Simons, K., Coskun, Ü., & Vattulainen, I. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503262112 · Cited by 171
Haas, Q., Boligan, K. F., Jandus, C., Schneider, C., Simillion, C., Stanczak, M. A., Haubitz, M., Jafari, S. M. S., Zippelius, A., Baerlocher, G. M., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0505 · Cited by 170
Organelle Specific O-Glycosylation Drives MMP14 Activation, Tumor Growth, and Metastasis
Nguyen, A. T., Chia, J., Ros, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.001 · Cited by 168
Glycosaminoglycan modification of neuropilin‐1 modulates VEGFR2 signaling
Shintani, Y., Takashima, S., Asano, Y., Kato, H., Liao, Y., Yamazaki, S., Tsukamoto, O., Seguchi, O., Yamamoto, H., Fukushima, T., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601188 · Cited by 167
Guo, H., Lee, I., Kamar, M., & Pierce, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308837200 · Cited by 153
Köhler, S., Ullrich, S., Richter, U., & Schumacher, U. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605492 · Cited by 147
ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues
Reis, C. A. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/e345 · Cited by 142
Self-citationPinho, S. S., Figueiredo, J., Cabral, J., Carvalho, S., Dourado, J., Magalhães, A., Gärtner, F., Mendonça, A. M., Isaji, T., Gu, J., et al. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.021 · Cited by 142
Self-citationLucena, M. C., Carvalho‐cruz, P., Donadio, J. L., Oliveira, I. D. A., de Queiroz, R. M., Marinho-Carvalho, M. M., Sola‐Penna, M., Paula, I. F. D., Gondim, K. C., McComb, M. E., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.729236 · Cited by 131
Britain, C. M., Holdbrooks, A. T., Anderson, J. C., Willey, C. D., & Bellis, S. L. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0385-0 · Cited by 129
A phase I study of swainsonine in patients with advanced malignancies.
Goss, P. E., Baptiste, J., Fernandes, B., Baker, M., & Dennis, J. W. (1994) · PubMed · Cited by 128
How Do Gangliosides Regulate RTKs Signaling?
Julien, S., Bobowski, M., Steenackers, A., Bourhis, X. L., & Delannoy, P. (2013) · Cells · doi:10.3390/cells2040751 · Cited by 127
Gomes, C., Osório, H., Pinto, M. T., Campos, D., Oliveira, M. J., & Reis, C. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066737 · Cited by 124
Self-citationEffect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition
Yen, H.-Y., Liu, Y.-C., Chen, N.-Y., Tsai, C.-F., Wang, Y.-T., Chen, Y.-J., Hsu, T.-L., Yang, P.-C., & Wong, C.-H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507329112 · Cited by 119
Cerliani, J. P., Stowell, S. R., Mascanfroni, I. D., Arthur, C. M., Cummings, R. D., & Rabinovich, G. A. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9494-2 · Cited by 110
Focused glycomic analysis of the N ‐linked glycan biosynthetic pathway in ovarian cancer
Abbott, K. L., Nairn, A. V., Hall, E. M., Horton, M. B., McDonald, J. F., Moremen, K. W., Dinulescu, D. M., & Pierce, M. (2008) · PROTEOMICS · doi:10.1002/pmic.200800157 · Cited by 109
A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor
Apostolopoulos, V., Yuriev, E., Ramsland, P. A., Halton, J., Osinski, C., Li, W., Plebanski, M., Paulsen, H. M., & McKenzie, I. F. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2432220100 · Cited by 97
MATSUMOTO, K. Y., Yokote, H., Arao, T., Maegawa, M., Tanaka, K., Fujita, Y., Shimizu, C., Hanafusa, T., Fujiwara, Y., & Nishio, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00847.x · Cited by 89
The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling
Jones, R. B., Dorsett, K. A., Hjelmeland, A. B., & Bellis, S. L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001194 · Cited by 87
Ito, K., & Ralph, S. J. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9471-7 · Cited by 75
Sambrooks, C. L., Baro, M., Quijano, A., Narayan, A., Cui, W., Greninger, P., Egan, R. K., Patel, A. A., Benes, C. H., Saltzman, W. M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0505 · Cited by 75
Mereiter, S., Magalhães, A., Adamczyk, B., Jin, C., Almeida, A., Drici, L., Ibáñez-Vea, M., Gomes, C., Ferreira, J. A., Afonso, L. P., et al. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.12.016 · Cited by 74
Self-citationHuman fucosyltransferase 6 enables prostate cancer metastasis to bone
Li, J., de Guillebon, A., Hsu, J.-W., Barthel, S. R., Dimitroff, C. J., Lee, Y., & King, M. R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.690 · Cited by 69
Chugh, S., Meza, J., Sheinin, Y. M., Ponnusamy, M. P., & Batra, S. K. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.116 · Cited by 66
GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy
Labrada, M., Dorvignit, D., Hevia, G., Rodríguez‐Zhurbenko, N., Hernández, A., Vázquez, A. M., & Fernandez, L. E. (2018) · Seminars in Oncology · doi:10.1053/j.seminoncol.2018.04.003 · Cited by 64
Cavdarli, S., Dewald, J. H., Yamakawa, N., Guérardel, Y., Terme, M., Doussal, J. L., Delannoy, P., & Groux‐Degroote, S. (2019) · Glycoconjugate Journal · doi:10.1007/s10719-018-09856-w · Cited by 53
Hou, S., Hang, Q., Isaji, T., Lu, J., Fukuda, T., & Gu, J. (2016) · The FASEB Journal · doi:10.1096/fj.201600665r · Cited by 50
Jacob, F., Alam, S., Konantz, M., Liang, C.-Y., Kohler, R. S., Everest‐Dass, A., Huang, Y., Rimmer, N., Fedier, A., Schötzau, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2223 · Cited by 49
Hang, Q., Isaji, T., Hou, S., Zhou, Y., Fukuda, T., & Gu, J. (2016) · Scientific Reports · doi:10.1038/srep33507 · Cited by 47
A PHASE I STUDY OF SWAINSONINE IN PATIENTS WITH ADVANCED MALIGNANCIES
Goss, P. E., Baptiste, J. J., Fernandes, B., Baker, M., & Dennis, J. W. (1993) · Journal of Immunotherapy · doi:10.1097/00002371-199311000-00053 · Cited by 46
Liu, N., Zhu, M., Linhai, Y., Song, Y., Gui, X., Tan, G., Li, J., Liu, Y., Deng, Z., Chen, X., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6680 · Cited by 42
Mehta, A. S., Comunale, M. A., Rawat, S., Casciano, J. C., Lamontagne, J., Herrera, H., Ramanathan, A. A., Rodemich-Betesh, L., Wang, M., Norton, P. A., et al. (2016) · Scientific Reports · doi:10.1038/srep27965 · Cited by 33
Isaji, T., Im, S., Kameyama, A., Wang, Y., Fukuda, T., & Gu, J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005208 · Cited by 33
Cited by
Pattern recognition receptors in health and diseases
Li, D., & Wu, M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00687-0 · Cited by 1,787
Global view of human protein glycosylation pathways and functions
Schjoldager, K. T., Narimatsu, Y., Joshi, H. J., & Clausen, H. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00294-x · Cited by 1,309
Cox, T. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00329-7 · Cited by 976
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics
Thomas, D., Rathinavel, A. K., & Radhakrishnan, P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188464 · Cited by 372
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
Metadata
- Authors
- Mereiter, S., Balmaña, M., Campos, D., Gomes, J., & Reis, C. A.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 36
- Issue
- 1
- Pages
- 6-16
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2960011166
- Cited by
- 565
- References
- 78
- FWCI
- 16.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.